Home › Studies › PRJNA764525
PRJNA764525 SRP337919

Bloodstream infections after FMT for GvHD, Israel

Bloodstream infections' origins following fecal microbiota transplantation: a strain-level analysis

37 stool samples from FMT donors and recipients at two Israeli medical centers (Chaim Sheba Medical Center and Rambam Health Care Campus), studying bloodstream infection origin after fecal microbiota transplantation for graft-versus-host-disease, case-control design. machine-written summary

37 samples · 37 runs · IL · Age unknown · 2021 · 0.79 Gbp / sample

Sources
✓Sequence archive 284○Abstract / description✓Full text 74✓Supplementary tables 1–External resources–User contribution–Human verified

Checked this project's papers and archive records yourself? Mark it human-verified.

what each source gave
✓ Sequence archive284 sample values (collection date, country, latitude, location locality, location region, location site, longitude, subject id)
○ Abstract / descriptionread; no usable statement
✓ Full text74 sample values (health condition, health condition detail) · PMC8791595
✓ Supplementary tables1 sample values (subject id)
– External resourcesnot covered by the external resources we ingest
– User contributionnothing uploaded yet
– Human verifiednot yet checked by a person · I checked this project — verify it
Interventions

intervention — arms not resolved

Faecal microbiota transplantation design observational_with_procedure · population transplant_or_immunocompromised · Fecal microbiota transplantation for graft-versus-host-disease, donor/recipient stool screening

“bloodstream infections (BSIs) following fecal microbiota transplantation (FMT)” — abstract:34644375 (study level; per-sample arms are in the intervention column below)

Samples at a glance
2 sampling locations · 1 country
Age
unknown37
Condition
autoimmune_inflammatory37
Country
IL37
Body site
primary36
excluded1
Collected 2017–2019
2017: 5 samples2018: 12 samples2019: 9 samples20172019
Sequencing depth per sample · this project all projects
all projects, 0–0.03 Gbp: 25,080 samples (4 %)all projects, 0.03–0.1 Gbp: 17,066 samples (3 %)all projects, 0.1–0.3 Gbp: 29,179 samples (5 %)this project, 0.1–0.3 Gbp: 6 samplesall projects, 0.3–1 Gbp: 47,044 samples (8 %)this project, 0.3–1 Gbp: 16 samplesall projects, 1–3 Gbp: 124,983 samples (22 %)this project, 1–3 Gbp: 8 samplesall projects, 3–10 Gbp: 253,728 samples (44 %)this project, 3–10 Gbp: 4 samplesall projects, 10–30 Gbp: 72,533 samples (13 %)this project, 10–30 Gbp: 3 samplesall projects, 30–100 Gbp: 3,024 samples (1 %)all projects, 100–300 Gbp: 106 samples (0 %)all projects, ≥ 300 Gbp: 9 samples (0 %)project median 0.79 Gbp per sample0130Gbp
Sampling design and relatedness

longitudinalFMT donor → recipient — not resolved

9 of 14 people sampled more than once (31 samples; median 4, up to 5 per person) · follow-up median 30 d (max 39 d) · median interval between samples 9 d (time from collection dates). Schedule stated by the source: “Multiple stool samples per patient collected on different dates (pre/post FMT) over observation period”.

M001M001: day 0M001: day 11M001: day 15M001: day 17M001: day 39M008M008: day 0M008: day 1M008: day 9M008: day 15M008: day 35M009M009: day 0M009: day 8M009: day 19M009: day 29M010M010: day 0M010: day 2M010: day 16M010: day 19M012M012: day 0M012: day 7M012: day 20M012: day 32M013M013: day 0M013: day 0M013: day 150 d10 d20 d29 d39 d

Each row is one person (6 shown of 9); dots are samples at days since that person's first sample.

FMT capsules (donor material, 10 capsules) + recipient stool and blood-culture samples from 13 patients; capsule-to-patient assignment not given (Table S4).

How longitudinal and relatedness information is derived

Community composition
Escherichia 13.3%Enterococcus_B 9.0%Bacteroides 5.6%Faecalibacterium 5.2%Lactobacillus 4.3%Ligilactobacillus 3.6%Lacticaseibacillus 3.1%Klebsiella 3.1%Streptococcus 2.8%Acinetobacter 2.8%Blautia_A 2.3%Gemmiger 2.2%not assigned to a genus 11.2%other genera 31.4%

Genera, mean relative abundance over 33 profiled gut samples of this project (Sandpiper SingleM profiles, GTDB R232; low-depth and non-metagenome profiles left out).

Field coverage
fieldsamplescoverageR1R2R3R4
age_category0 0%
country37 100%37
health_condition37 100%37
subject_id37 100%361
detailed_location37 100%
health_condition_detail37 100%37
latitude37 100%37
location_locality37 100%37
location_region37 100%37
location_site37 100%37
longitude37 100%37
collection_date26 70%26
Papers (1)
  • Origins of bloodstream infections following fecal microbiota transplantation: a strain-level analysis. 2022 PMID 34644375 PMC8791595 own_data
Details
Archive description

We observed high rates of bloodstream infections (BSIs) following fecal microbiota transplantation (FMT) for graft-versus-host-disease (33 events in 22 patients). To trace the BSIs' origin, we applied a metagenomic bioinformatic pipeline screening donor and recipient stool samples for bacteremia-causing strains in 13 cases. Offending strains were not detected in FMT donations. Enterococcus faecium, Escherichia coli, Pseudomonas aeruginosa, and Acinetobacter baumannii could be detected in stool samples before emerging in the blood. In this largest report of BSIs post-FMT, we present an approach that may be applicable for evaluating BSI origin following microbiota-based interventions. Our findings support FMT safety in immunocompromised patients but do not rule out FMT as an inducer of bacterial translocation.

How this project entered the registry

Classified as human gut / stool shotgun DNA metagenome of age unknown by opus_adjudicated with confidence 0.80. Assay shotgun_dna.

  • host run.host_tax_id · “9606”
  • host run.scientific_name · “human gut metagenome”
  • body site study.description · “donor and recipient stool samples”
Evidence examples (one per field × route)
samplefieldvaluerouteconf.sourcequote
SAMN21507521collection_date2017-07-09R10.90biosample.attribute:collection_date2017-07-09
SAMN21507521countryILR10.90sample.attr.geo_loc_nameIsrael: Chaim Sheba Medical Center, Tal Hashomer, Ramat Gan
SAMN21507521health_conditionautoimmune_inflammatoryR30.70paper.fulltext.methodssteroid-resistant or steroid-dependent acute GVHD
SAMN21507521health_condition_detailsteroid-resistant/steroid-dependent acute graft-versus-host-disease (GVHD)R30.70paper.fulltext.methodssteroid-resistant or steroid-dependent acute GVHD
SAMN21507521latitude32.0700R10.90biosample.attribute:lat_lon32.07 N 34.84 E
SAMN21507521location_localityRamat GanR10.85biosample.attribute:geo_loc_nameIsrael: Chaim Sheba Medical Center, Tal Hashomer, Ramat Gan
SAMN21507521location_regionTel AvivR10.60biosample.attribute:lat_lon32.07 N 34.84 E
SAMN21507521location_siteChaim Sheba Medical CenterR10.85biosample.attribute:geo_loc_nameIsrael: Chaim Sheba Medical Center, Tal Hashomer, Ramat Gan
SAMN21507521longitude34.8400R10.90biosample.attribute:lat_lon32.07 N 34.84 E
SAMN21507521subject_idM001R10.70sample.name_rule:titleStool sample for patient M001 from 09/07/2017
SAMN21507546subject_idR001R20.85paper.supp.advancesADV2021005110-suppl1.pdf[p6t1!Patient/ donor number]R001
Sequencing

37 runs over 37 samples · mean 2.24 Gbp per run (median 0.79 Gbp, total 82.77 Gbp; 37 runs with a base count) · layout PAIRED 37 · platform ILLUMINA 37 · models Illumina HiSeq 2500 (37) · 92% of runs with a Sandpiper profile · first public 2021-11-01

Authors (13)

Eshel A first · Sharon I · Nagler A · Bomze D · Danylesko I · Fein JA · Geva M · Henig I · Shimoni A · Zuckerman T · Youngster I · Koren O · Shouval R last

Downloads

PRJNA764525.csv.gz (2.2 KB) · parquet (72.6 KB) — all 37 samples, every field with route and confidence · PRJNA764525_determinations.csv.gz (3.8 KB) — 359 evidence rows

Samples (37 · every field this project has values for · hover a cell for its source)
Loading the sample table…